Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Dow
Moodys
Harvard Business School
McKesson
AstraZeneca

Last Updated: December 13, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Oglemilast

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What is the drug development status for Oglemilast?

Oglemilast is an investigational drug.

There have been 4 clinical trials for Oglemilast. The most recent clinical trial was a Phase 2 trial, which was initiated on May 1st 2006.

The most common disease conditions in clinical trials are Asthma, Lung Diseases, and Chronic Disease. The leading clinical trial sponsors are Forest Laboratories, Glenmark Pharmaceuticals Europe Ltd. (R&D), and [disabled in preview].

Recent Clinical Trials for Oglemilast
TitleSponsorPhase
A Clinical Study of Oglemilast in Patients With Mild to Moderate Persistent AsthmaGlenmark Pharmaceuticals Europe Ltd. (R&D)Phase 2
Study To Assess Efficacy and Safety of Oglemilast in Patients With Chronic Obstructive Pulmonary Disease (COPD)Forest LaboratoriesPhase 2
Study of Oglemilast for the Prevention of Asthma.Forest LaboratoriesPhase 2

See all Oglemilast clinical trials

Clinical Trial Summary for Oglemilast

Top disease conditions for Oglemilast
Top clinical trial sponsors for Oglemilast

See all Oglemilast clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
McKinsey
Mallinckrodt
Harvard Business School
AstraZeneca
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.